Skip to main content
. Author manuscript; available in PMC: 2017 Nov 8.
Published in final edited form as: Neuroimmunomodulation. 2016 Nov 8;23(4):224–229. doi: 10.1159/000450581

Table 1. Demographics and Descriptives and pSTAT1 levels in CON-LOW, SZ-LOW and SZ-HIGH groups.

Demographics and Mean pSTAT1 for Participant Sub-Groups

CON-LOW
pSTAT1
(N=13)
SZ-LOW
pSTAT1
(N=13)
SZ-HIGH
pSTAT1
(N=9)
P-value
Sex N N N n.s
Males 5 10 7
Females 8 3 2
Age (Mean±SD) 38.1 ±11.6 39.5 ±12.5 38.2 ±11.9 n.s
Race N N N n.s
Caucasian, non-Hispanic 1 0 1
Black, non-Hispanic 8 10 8
Asian or other pacific Islander 2 0 0
Hispanic 2 3 0
BMI (Mean±SD) 29.8 ±7.5 35.1 ±8.6 31.2 ±9.6 n.s
Medication Yes No Yes No Yes No
Typical Antipsychotics 0 13 3 10 0 9
Atypical Antipsychotics 0 13 11 2 8 1
Mean pSTAT1 OD
Levels/Total H3
0.14 0.08 0.46 P<0.001
Standard Deviation 0.10 0.04 0.18
Standard Error 0.03 0.01 0.06